Trial Outcomes & Findings for Building a Multidisciplinary Research Program to Address Hypertension Disparities: Exploring the Neurocognitive Mechanisms of a Self-Management Intervention for African American Women (NCT NCT04266704)

NCT ID: NCT04266704

Last Updated: 2026-09-01

Results Overview

fMRI protocol - Each participant was presented the same conditions, in the same order . A fixed sequence design was used because the primary goal was to compare patterns of brain activity between participants. Means are estimated averages of each participant's response to video conditions.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

50 participants

Primary outcome timeframe

6 months

Results posted on

2026-09-01

Participant Flow

Participant milestones

Participant milestones
Measure
Control
education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence
Intervention
Along with providing education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence, the intervention arm is designed to promote information sharing and stimulate broad cortical neural networks, the default mode (DMN), which focuses on emotion-management and self-awareness.
Overall Study
STARTED
25
25
Overall Study
COMPLETED
19
13
Overall Study
NOT COMPLETED
6
12

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

subset of sample

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
n=25 Participants
Women who self-identified as African American/Black and stated they had been diagnosed with hypertension
Intervention
n=25 Participants
Women who self-identified as African American/Black and stated they had been diagnosed with hypertension
Total
n=50 Participants
Total of all reporting groups
Age, Continuous
53.04 years
STANDARD_DEVIATION 7.60 • n=25 Participants
51.00 years
STANDARD_DEVIATION 8.67 • n=25 Participants
52.02 years
STANDARD_DEVIATION 8.13 • n=50 Participants
Sex: Female, Male
Female
25 Participants
n=25 Participants
25 Participants
n=25 Participants
50 Participants
n=50 Participants
Sex: Female, Male
Male
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Race (NIH/OMB)
Asian
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Race (NIH/OMB)
Black or African American
25 Participants
n=25 Participants
25 Participants
n=25 Participants
50 Participants
n=50 Participants
Race (NIH/OMB)
White
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
25 Participants
n=25 Participants
25 Participants
n=25 Participants
50 Participants
n=50 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=25 Participants
0 Participants
n=25 Participants
0 Participants
n=50 Participants
Brain Activity
0.18 Values reflect % change in BOLD response
STANDARD_DEVIATION 0.41 • n=3 Participants • subset of sample
0.00 Values reflect % change in BOLD response
STANDARD_DEVIATION 0.42 • n=3 Participants • subset of sample
0.09 Values reflect % change in BOLD response
STANDARD_DEVIATION 0.42 • n=6 Participants • subset of sample
Systolic Blood Pressure
129.72 mm Hg
STANDARD_DEVIATION 13.79 • n=25 Participants
132.56 mm Hg
STANDARD_DEVIATION 17.41 • n=25 Participants
131.14 mm Hg
STANDARD_DEVIATION 15.61 • n=50 Participants
Diastolic Blood Pressure
86.44 mm Hg
STANDARD_DEVIATION 9.85 • n=25 Participants
87.08 mm Hg
STANDARD_DEVIATION 8.72 • n=25 Participants
86.76 mm Hg
STANDARD_DEVIATION 9.21 • n=50 Participants
PROMIS - Mental Health
3.16 scores on a scale
STANDARD_DEVIATION 0.69 • n=25 Participants
3.04 scores on a scale
STANDARD_DEVIATION 0.61 • n=25 Participants
3.10 scores on a scale
STANDARD_DEVIATION 0.65 • n=50 Participants
PROMIS - Physical Health
3.12 scores on a scale
STANDARD_DEVIATION 0.53 • n=25 Participants
3.24 scores on a scale
STANDARD_DEVIATION 0.44 • n=25 Participants
3.18 scores on a scale
STANDARD_DEVIATION 0.48 • n=50 Participants

PRIMARY outcome

Timeframe: 6 months

Population: Due to the cost of conducting fMRI, the study was designed to evaluate brain activity in a subset of participants. At baseline, the recruitment target was met (n =10). However, due to participant drop out - the final number of fMRI scans available for analysis was n = 5.

fMRI protocol - Each participant was presented the same conditions, in the same order . A fixed sequence design was used because the primary goal was to compare patterns of brain activity between participants. Means are estimated averages of each participant's response to video conditions.

Outcome measures

Outcome measures
Measure
Intervention
n=3 Participants
Along with providing education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence, the intervention arm is designed to promote information sharing and stimulate broad cortical neural networks, the default mode (DMN), which focuses on emotion-management and self-awareness.
Control
n=2 Participants
education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence
Brain Activity
0.08 Values reflect % change in BOLD response
Standard Deviation 0.38
0.29 Values reflect % change in BOLD response
Standard Deviation 0.26

SECONDARY outcome

Timeframe: 6 months

Population: participant drop out

Blood pressure was measured using automated sphygmomanometer based on standardized protocols.

Outcome measures

Outcome measures
Measure
Intervention
n=13 Participants
Along with providing education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence, the intervention arm is designed to promote information sharing and stimulate broad cortical neural networks, the default mode (DMN), which focuses on emotion-management and self-awareness.
Control
n=19 Participants
education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence
Systolic Blood Pressure
129.62 mm Hg
Standard Deviation 13.19
134.89 mm Hg
Standard Deviation 16.41

SECONDARY outcome

Timeframe: 6 months

Population: participant drop out

Blood pressure was measured using automated sphygmomanometer based on standardized protocols.

Outcome measures

Outcome measures
Measure
Intervention
n=13 Participants
Along with providing education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence, the intervention arm is designed to promote information sharing and stimulate broad cortical neural networks, the default mode (DMN), which focuses on emotion-management and self-awareness.
Control
n=19 Participants
education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence
Diastolic Blood Pressure
85.31 mmHg
Standard Deviation 7.35
88.00 mmHg
Standard Deviation 11.30

SECONDARY outcome

Timeframe: 6 months

Population: participant drop out

Health-related quality of life was measured with the PROMIS Global Scale. This 10-item measured the overall physical, mental, and social health of adults. Items range from (1 = never to 5 = always) on a Likert-type scale. Higher scores indicate better quality of life.

Outcome measures

Outcome measures
Measure
Intervention
n=13 Participants
Along with providing education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence, the intervention arm is designed to promote information sharing and stimulate broad cortical neural networks, the default mode (DMN), which focuses on emotion-management and self-awareness.
Control
n=19 Participants
education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence
PROMIS - Mental Health
2.92 scores on a scale
Standard Deviation 0.64
3.00 scores on a scale
Standard Deviation 0.58

SECONDARY outcome

Timeframe: 6 months

Population: participant dropout

Health-related quality of life was measured with the PROMIS Global Scale. This 10-item measured the overall physical, mental, and social health of adults. Items range from (1 = never to 5 = always) on a Likert-type scale. Higher scores indicate better quality of life.

Outcome measures

Outcome measures
Measure
Intervention
n=13 Participants
Along with providing education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence, the intervention arm is designed to promote information sharing and stimulate broad cortical neural networks, the default mode (DMN), which focuses on emotion-management and self-awareness.
Control
n=19 Participants
education on a low sodium diet (Dietary Approaches to Stop Hypertension or DASH), exercise, and medication adherence
PROMIS - Physical Health
2.92 scores on a scale
Standard Deviation 0.28
3.11 scores on a scale
Standard Deviation 0.32

Adverse Events

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Lenette Jones

University of Michigan

Phone: 7347631371

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place